Jennison Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,420
| Closed | -$2.13M | – | 620 |
|
|
2022
Q2 | $2.13M | Buy |
+4,420
| New | +$2.19M | ﹤0.01% | 460 |
|
|
2021
Q1 | – | Sell |
-149,002
| Closed | -$47.8M | – | 685 |
|
|
2020
Q4 | $47.8M | Buy |
149,002
+50,862
| +52% | +$15.6M | 0.03% | 213 |
|
|
2020
Q3 | $26.4M | Buy |
98,140
+507
| +0.5% | +$136K | 0.02% | 277 |
|
|
2020
Q2 | $25.7M | Sell |
97,633
-40,293
| -29% | -$10.7M | 0.02% | 258 |
|
|
2020
Q1 | $31.3M | Buy |
137,926
+1,198
| +0.9% | +$326K | 0.04% | 195 |
|
|
2019
Q4 | $41.3M | Buy |
136,728
+1,518
| +1% | +$418K | 0.04% | 208 |
|
|
2019
Q3 | $32.5M | Sell |
135,210
-80,589
| -37% | -$22.1M | 0.03% | 247 |
|
|
2019
Q2 | $60.9M | Buy |
215,799
+24,638
| +13% | +$6.73M | 0.06% | 177 |
|
|
2019
Q1 | $54.9M | Buy |
191,161
+28
| +0% | +$8.1K | 0.05% | 208 |
|
|
2018
Q4 | $50.2M | Buy |
191,133
+1,994
| +1% | +$548K | 0.06% | 205 |
|
|
2018
Q3 | $51.8M | Buy |
+189,139
| New | +$49.1M | 0.05% | 250 |
|
|
2017
Q3 | – | Sell |
-15,005
| Closed | -$2.82M | – | 669 |
|
|
2017
Q2 | $2.82M | Sell |
15,005
-2,567
| -15% | -$461K | ﹤0.01% | 525 |
|
|
2017
Q1 | $2.91M | Sell |
17,572
-875
| -5% | -$139K | ﹤0.01% | 526 |
|
|
2016
Q4 | $2.65M | Sell |
18,447
-7,641
| -29% | -$1.02M | ﹤0.01% | 538 |
|
|
2016
Q3 | $3.27M | Buy |
26,088
+1,973
| +8% | +$255K | ﹤0.01% | 530 |
|
|
2016
Q2 | $3.17M | Buy |
24,115
+517
| +2% | +$70.7K | ﹤0.01% | 521 |
|
|
2016
Q1 | $3.28M | Sell |
23,598
-2,297
| -9% | -$307K | ﹤0.01% | 507 |
|
|
2015
Q4 | $3.61M | Buy |
25,895
+1,879
| +8% | +$259K | ﹤0.01% | 528 |
|
|
2015
Q3 | $3.36M | Buy |
+24,016
| New | +$3.61M | ﹤0.01% | 560 |
|
|
2013
Q3 | – | Sell |
-37,519
| Closed | -$3.07M | – | 695 |
|
|
2013
Q2 | $3.07M | Buy |
+37,519
| New | +$2.81M | ﹤0.01% | 508 |
|
Other funds holding ELV
